234 filings
Page 5 of 12
8-K
rl6jep7
29 Mar 18
Results of Operations and Financial Condition
12:00am
8-K
1yrtnx00s8jarotc
23 Mar 18
Casi Pharmaceuticals Announces $50 Million Private Placement to Prepare Company for Commercialization In China
12:00am
8-K
aoq9pl16nt ckcxe
16 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
pxuy9n re
23 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
uacpvdqjarsuv
9 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
ljxbqbmyuyl4zc yzl
26 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
aiv7t5q4 us9c10
22 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
2kghkn9z 3y
8 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
tososgyqur59z
14 Nov 17
Casi Pharmaceuticals Reports Third Quarter 2017 Financial Results
12:00am
8-K
prhtrp7lerhbdukohj
19 Oct 17
Casi Pharmaceuticals Announces $23.8 Million Registered Direct Offering Led by Existing Shareholders
12:00am
8-K
ievo uvnijz
7 Sep 17
Casi Provides Pipeline Development Update
12:00am
8-K
9a6lzd5ca0m xpd6
14 Aug 17
Casi Pharmaceuticals Reports Second Quarter 2017 Financial Results
12:00am
8-K
1zlionq6 tpfy
9 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
66xmdl pg2kmxk89k00
15 May 17
Casi Pharmaceuticals Reports First Quarter 2017 Financial Results
12:00am
8-K
tq0 99h2khg0nc5dx
31 Mar 17
Casi Pharmaceuticals Reports 2016 Fourth Quarter and Full Year Financial Results
12:00am
8-K
jxifae2rbl 5l02e
16 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
e9y2h6aptzdj4h3 kn
14 Nov 16
Casi Pharmaceuticals Reports Third Quarter 2016 Financial Results
12:00am
8-K
1ul6 1xqksqxf7n
25 Oct 16
Entry into a Material Definitive Agreement
12:00am
8-K
5m6pzsn
5 Oct 16
Unregistered Sales of Equity Securities
12:00am
8-K
x6uslx
15 Aug 16
Casi Pharmaceuticals Reports Second Quarter 2016 Financial Results
12:00am